GLP-1 medications have transformed weight loss conversations and genuinely helped many people. I acknowledge their value — and I also want to raise an important question: what’s happening internally, particularly in the gut, and how does this affect long-term results for women navigating perimenopause and menopause?
A Quick Primer: What Is GLP-1, Really?
GLP-1 (glucagon-like peptide-1) is naturally produced in the body by specialized cells in the lower small intestine and colon. Its functions include:
- Signaling fullness to the brain
- Slowing stomach emptying for sustained satisfaction
- Supporting balanced blood sugar
- Coordinating appetite with nutrient availability
In healthy systems, GLP-1 is released after we eat — especially when food reaches the lower gut and interacts with a diverse, well-functioning gut microbiome. This is important context for everything that follows.
The Gut Microbiome: The Missing Piece in the GLP-1 Conversation
A critical and often overlooked fact: efficient GLP-1 production depends on healthy gut bacteria. When the microbiome is compromised — through low diversity, unfavorable bacteria overgrowth, inflammation, or impaired digestion — the signaling that triggers natural GLP-1 release weakens significantly.
When women turn to GLP-1 medications, the question worth asking is: why is natural GLP-1 signaling insufficient in the first place? In many cases, the answer is a compromised gut microbiome. The medication bypasses the problem rather than addressing it.
What Clinicians Observe in GLP-1 Users
One of the consistent findings in comprehensive gut testing of women on these medications is putrefaction — when protein lingers in the digestive tract and bacteria break it down in ways that produce harmful byproducts. GLP-1 medications intentionally slow digestion (slower gastric emptying), which allows protein to remain longer in the gut and potentially cause bacterial fermentation that produces compounds like ammonia and phenols, increasing inflammation.
This doesn’t make GLP-1 medications wrong for everyone. It does mean that gut health before, during, and after use is clinically significant.
Hormonal Considerations for Midlife Women
Estrogen and gut microbiota are deeply interconnected. During perimenopause and menopause, predictable shifts occur:
- Reduced microbial diversity
- Loss of bacteria involved in estrogen metabolism (the estrobolome)
- Increased insulin resistance and inflammation
These changes make appetite regulation and weight maintenance more challenging — which is often what drives women toward GLP-1 medications in the first place. The medications don’t address these underlying hormonal shifts; they work around them.
Muscle Loss, Metabolism, and Rebound Weight Gain
Weight loss on GLP-1 medications is not purely fat loss. Without intentional support, women may lose muscle mass, metabolic flexibility, and strength alongside fat. This matters enormously, because:
- Muscle is your primary driver of resting metabolic rate
- Muscle preserves bone density, which is already under hormonal pressure in perimenopause
- Muscle is protective against insulin resistance and cardiovascular disease
If GLP-1 medications are stopped without having addressed gut health and built a foundation of muscle-preserving habits, the result is often rapid weight regain — with less muscle and more fat than before.
A Gut- and Hormone-Forward Approach
Rather than viewing GLP-1 medications as inherently problematic, I think of them as tools that work best when the gut and hormonal foundations are in place. My approach emphasizes:
- Healing and diversifying the gut microbiome to restore natural appetite signaling
- Improving digestion and nutrient absorption
- Supporting estrogen balance through the gut-hormone axis
- Preserving and building lean muscle through strategic resistance training and adequate protein
When these foundations are strengthened, natural GLP-1 signaling improves and hunger cues become more reliable. For some women, this approach makes medication unnecessary. For others, it makes medication more effective and the transition off it more sustainable.
GLP-1 medications can be powerful. Gut health is foundational. Women deserve an approach that respects both.
Ready to look at the full picture?
A discovery conversation is a no-pressure way to understand what testing and a personalized approach could look like for you.
The content on this blog is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making changes to your diet, supplements, or health protocols.